Drug resistance of Gram-negative Bacilli in patients in NICU from 2011 to 2013

Jun TIAN,Xiu-mei ZHU,Qi LI,Li-yan CHI,Liang-feng WEI,Zhao-cong ZHENG,Shou-sen WANG
DOI: https://doi.org/10.13798/j.issn.1009-153X.2016.07.011
2016-01-01
Abstract:Objective To study the drug resistance of Gram-negative bacilli in the patients in neurosurgery intensive care unit (NICU) in order to provide guidance for the rational use of antibiotics. Method From January, 2011 to December, 2013, the antimicrobial susceptibility test was performed in the Gram-negative bacilli isolated from the patients in NICU by minimum inhibitory concentration method. The results were analyzed by WHONET 5.3 Software. Results The first three pathogens of 363 strains were Acinetobacter spp (34.7%), Pseudomonas aeruginosa (24.5%) and Klebsiella pneumonia (20.4%) respectively. The resistance rate of Acinetobacter spp to amikacin and cefoperazone-sulbactam were 4.0% and 15.9% respectively. The resistance rate of pseudomonas aeruginosa to piperacillin-tazobactam was about 33.3%. Conclusions In NICU, imipenem cefoperazone-sulbactam and piperacillin-tazobactam remain high activity against Gram-negative bacilli in NICU.
What problem does this paper attempt to address?